奥氮平所致的抗精神病药恶性综合征。
Olanzapine-induced Neuroleptic Malignant Syndrome.
作者信息
Saha Pradeep Kumar, Chakraborty Abhijit, Layek Avik Kumar, Chakraborty Aritra
机构信息
Department of Psychiatry, Institute of Psychiatry, Kolkata, West Bengal, India.
出版信息
Indian J Psychol Med. 2017 May-Jun;39(3):364-365. doi: 10.4103/0253-7176.207320.
Abstract
Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also. A 19-year-old male diagnosed as a case of acute and transient psychotic disorder developed NMS, following the treatment with an atypical antipsychotic, olanzapine 20 mg/day. The patient was diagnosed NMS, an offending agent olanzapine was immediately withdrawn, and prompt treatment by maintaining hydration and giving bromocriptine produced recovery.
摘要
抗精神病药恶性综合征（NMS）是一种危及生命的不良反应，通常见于典型抗精神病药物。非典型抗精神病药物也很少会引发NMS。一名19岁男性被诊断为急性短暂性精神病性障碍，在接受非典型抗精神病药物奥氮平20毫克/天治疗后出现了NMS。该患者被诊断为NMS，立即停用了致病药物奥氮平，并通过维持水合作用和给予溴隐亭进行及时治疗，患者最终康复。
相似文献
1
Olanzapine-induced Neuroleptic Malignant Syndrome.奥氮平所致的抗精神病药恶性综合征。
Indian J Psychol Med. 2017 May-Jun;39(3):364-365. doi: 10.4103/0253-7176.207320.
2
Olanzapine induced neuroleptic malignant syndrome.奥氮平引起的神经阻滞剂恶性综合征。
Indian J Pharmacol. 2013 Jan-Feb;45(1):98-9. doi: 10.4103/0253-7613.106448.
3
Olanzapine-Induced Neuroleptic Malignant Syndrome.奥氮平所致的抗精神病药恶性综合征
Iran J Med Sci. 2017 May;42(3):306-309.
4
Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.一名长期服用稳定剂量奥氮平的患者发生抗精神病药恶性综合征：用丹曲林成功治疗。
Brain Inj. 2015;29(5):658-60. doi: 10.3109/02699052.2014.1002002. Epub 2015 Jan 27.
5
Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.一名接受非典型抗精神病药物治疗的儿童发生了抗精神病药恶性综合征。
J Toxicol Clin Toxicol. 2004;42(6):921-5. doi: 10.1081/clt-200035214.
6
Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.奥氮平引起的神经阻滞剂恶性综合征，表现为需要血液透析的严重急性肾损伤：一例报告。
J Med Case Rep. 2022 Oct 6;16(1):366. doi: 10.1186/s13256-022-03591-5.
7
Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?一名双相情感障碍患者出现奥氮平诱发的抗精神病药恶性综合征：喹硫平是解决办法吗？
Ind Psychiatry J. 2013 Jul;22(2):159-60. doi: 10.4103/0972-6748.132934.
8
[Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].[氯氮平相关的抗精神病药恶性综合征继发紧张症：一例报告]
Turk Psikiyatri Derg. 2013 Summer;24(2):140-4.
9
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物：简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
10
Atypical neuroleptic malignant syndrome - A case report.非典型神经阻滞剂恶性综合征 - 病例报告。
Asian J Psychiatr. 2019 Jun;43:7-8. doi: 10.1016/j.ajp.2019.04.007. Epub 2019 Apr 30.
引用本文的文献
1
Malignant hyperthermia in severe COVID-19: 2 case reports.重症新型冠状病毒肺炎中的恶性高热：2例病例报告
Emerg Crit Care Med. 2021 Sep 15;1(1):45-48. doi: 10.1097/EC9.0000000000000013. eCollection 2021 Sep.
2
Acute and transient psychotic disorders: A review of Indian research.急性短暂性精神病性障碍：印度研究综述
Indian J Psychiatry. 2023 Sep;65(9):895-913. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_254_23. Epub 2023 Sep 5.
3
Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature.一名抗N-甲基-D-天冬氨酸受体脑炎患者的抗精神病药恶性综合征：病例报告及相关文献综述
Neurohospitalist. 2022 Jan;12(1):80-85. doi: 10.1177/19418744211002978. Epub 2021 Mar 19.
4
Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene.使用丹曲林对抗精神病单药治疗引起的神经阻滞剂恶性综合征进行紧急治疗。
Clin Pract Cases Emerg Med. 2019 Jan 4;3(1):16-23. doi: 10.5811/cpcem.2018.11.39667. eCollection 2019 Feb.
本文引用的文献
1
Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?一名双相情感障碍患者出现奥氮平诱发的抗精神病药恶性综合征：喹硫平是解决办法吗？
Ind Psychiatry J. 2013 Jul;22(2):159-60. doi: 10.4103/0972-6748.132934.
2
Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.与非典型抗精神病药物相关的神经阻滞剂恶性综合征。
CNS Drugs. 2009;23(6):477-92. doi: 10.2165/00023210-200923060-00003.
3
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物：简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
4
Olanzapine induced neuroleptic malignant syndrome--a case review.奥氮平诱发的抗精神病药恶性综合征——病例回顾
Hum Psychopharmacol. 2003 Jun;18(4):301-9. doi: 10.1002/hup.483.
5
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
6
Preventability and severity assessment in reporting adverse drug reactions.药品不良反应报告中的可预防性和严重程度评估
Am J Hosp Pharm. 1992 Sep;49(9):2229-32.
Zotero 插件